1 active not recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
Follow IDH2 Gene Mutation: new trials by email Literature Review of IDH2 Gene Mutation trials Research Report on IDH2 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib In Recurrent IDH 1/2 Gliomas Niraparib, Resection/Treatment with Niraparib - Low-grade Glioma, IDH2 Gene Mutation | Early Phase 1 | Active not recruiting | Massachusetts General Hospital | 16 | 2023-05-18 | 2026-07-24 |
Glioma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
Therapeutics (1) · niraparib (1)
Massachusetts General Hospital (1)
United States (1)